Drug Profile
Research programme: protein therapeutics - Affibody AB/Biotest AG
Latest Information Update: 27 Apr 2022
Price :
$50
*
At a glance
- Originator Biotest AG
- Developer Affibody; Biotest AG
- Class Blood coagulation factors; Proteins
- Mechanism of Action Blood coagulation modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Haemophilia